CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 25 USA ABOUT SHAUN CHILTON Shaun has played a pivotal role in the development of Clinigen, joining the company in January 2012 as Chief Operating Officer, when it was a privately owned company with a turnover of £82m. He was a key part of the executive team that took Clinigen through IPO in September 2012. Then as deputy CEO in 2015 and CEO from November 2016, has been a fundamental part of the leadership of the impressive strategic growth of the company from £135m market capitalisation in 2012 to its current position as one of the largest companies on AIM on the London Stock Exchange with a turnover of c£400m. Clinigen has grown rapidly since its inception through a combination of strong organic growth and strategic transformational acquisitions to become a global specialty pharmaceutical and pharmaceutical services company. In 2017, Shaun oversaw the largest M&A healthcare deal of the year in the UK with the successful acquisition of Quantum, in addition to acquiring the largest supplier of unlicensed medicines in Japan, IMMC. 2018 saw further corporate acquisitions (CSM and iQone) and pharmaceutical assets (Imukin and Proleukin) that continued to build and stregthen theGroup’s capabilities. Shaun was awarded the Entrepreneur of the Year Healthcare (Western Europe) in 2017 and 2018 by the European CEO Awards. Prior to joining Clinigen, Shaun held senior global strategic, commercial and operational roles at Pfizer, Sanofi, Wolters Kluwer Health and the KnowledgePoint360 Group (now part of UDG Healthcare). SHAUN CHILTON Group Chief Executive Officer of Clinigen Group FIRM PROFILE Clinigen (ClinigenGroup) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines to improve the quality of people’s lives around the world. We are the global leading experts, trusted by both pharmaceutical and biotech companies and healthcare professionals, in providing access to medicines throughout the lifecycle of a medicine; clinical trials, unlicensed and commercial supply. Clinigen’s mission is to deliver the right medicine to the right patient at the right time operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines. Operating in a complexregulatoryenvironment,Clinigenistheonly company to globally manage access to medicine across all three routes worldwide. We understand the complex challenges facing Pharmaceutical and Biotech companies and are uniquely placed to provide the solutions to help.Clinigen add insight, expertise and value at every stage of a product’s lifecycle, supporting pharmaceutical companies and healthcare professionals from clinical trials, unlicensed supply and full commercialisation of medicines. That is why, for over 30 years, Clinigen has been trusted by industry and healthcare providers to enable access to more innovative medicines, in more countries, for more patients than anyone else. CONTACT Shaun Chilton Clinigen Group plc, Pitcairn House, First Avenue, Burton-upon-Trent DE14 2WW “Operating in a complex regulatory environment, Clinigen is the only company to globally manage access to medicine across all three routes worldwide. We understand the complex challenges facing Pharmaceutical and Biotech companies and are uniquely placed to provide the solutions to help.”